The Future Is Bright: Advances and Developments in Flow Cytometry

Kate has a BSc in Microbiology from the University of Manchester and a PhD in virology from the University of Edinburgh. Following this, she completed a post-doc at the Jenner Institute, University of Oxford, developing vaccines for neglected tropical diseases including dengue and zika viruses. She later moved to a lectureship position at the University of Chester, teaching immunology as well as initiating a research project examining the immunology of pregnancy and breast milk. Realising that her passion lay in science communication and public engagement rather than in the lab, Kate made the leap into science writing in 2022. She now works at Technology Networks as a senior science writer, where she is responsible for the creation of custom written content.

Polly Fordyce is an Associate Professor of Bioengineering and Genetics and Institute Scholar of ChEM-H at Stanford, where her lab develops and applies new microfluidic platforms for quantitative and high-throughput biophysics, biochemistry and single-cell biology. She graduated from the University of Colorado at Boulder with undergraduate degrees in physics and biology before moving to Stanford University, where she earned a PhD in physics for work with Professor Steve Block developing instrumentation and assays for single-molecule studies of kinesin motor proteins. For her postdoctoral research, she worked with Professor Joe DeRisi to develop a new microfluidic platform for understanding how transcription factors recognize and bind their DNA targets as well as a new technology for bead-based multiplexing. She is the recipient of an NSF CAREER Award, NIH New Innovator and Pioneer Awards, the Stanford President’s Award for Excellence in Diversity and she is a Chan Zuckerberg Biohub Investigator.

John Nolan received BS degrees in biology and chemistry from the University of Illinois and a PhD in biochemistry from Penn State University. He did post-doctoral research at Los Alamos National Laboratory and was the director of the National Flow Cytometry Resource there. He is an elected Fellow of the American Institute for Medical and Biological Engineering, past-president of the International Society for Advancement of Cytometry and founder of Cellarcus Biosciences, which provides products and services for extracellular vesicle research.

Dr. Robinson received his early education at the University of NSW, Sydney, Australia where he received BSc (Hons), MSc and PhD degrees. He was a postdoctoral fellow in the University of Michigan Medical School. Dr. Robinson is currently the Distinguished Professor of Cytometry and professor of biomedical engineering in the Weldon School of Biomedical Engineering. Dr. Robinson is a Fellow of the American Institute for Medical and Biological Engineering, the American Association for the Advancement of Science, the National Academy of Inventors and the Royal Microscopy Society. Dr. Robinson is a past president of the International Society for Advancement of Cytometry and is the past Editor-in-Chief of Current Protocols in Cytometry. In 2006, he formed the not-for-profit foundation “Cytometry for Life” to promote low-cost diagnostics and education primarily in Africa. This organization continues to work today to expand education and training in Africa in conjunction with AIBBC.